88
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Schizophrenia in Late Life: Findings Challenge Traditional Concepts

, &
Pages 51-58 | Published online: 03 Jul 2009

REFERENCES

  • Bleuler E. Dementia praecox, or the group of schizophrenias. Zinkin J, trans. New York: International Universities Press, 1950.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Ameri- can Psychiatric Association, 1994.
  • Jeste DV. Growing disparity between need and reality: re- search in geriatric psychiatry. Curr Opin Psychiatry 1996; 9:279–80.
  • Palmer BW, Heaton SC, Jeste DV. Older patients with schizo- phrenia: challenges in the coming decades. Psychiatr Serv 1999;50:1178–83.
  • Wender PH. Dementia praecox: the development of the con- cept. Am J Psychiatry 1963;119:1143–51.
  • Schneider K. Clinical psychopathology. Hamilton MW, trans. 5th ed. New York: Grune & Stratton, 1959.
  • Kraepelin E. Dementia praecox and paraphrenia. Barclay RM, trans. Huntington, New York: Krieger, 1971.
  • Roth M. The natural history of mental disorder in old age. J Mental Sci 1955;101:281–301.
  • Bleuler M. The schizophrenic disorders: long-term patient and family studies. Clemens SM, trans. New Haven, Connecticut: Yale University Press, 1978.
  • Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57–63.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: Ameri- can Psychiatric Press, 1980.
  • Howard R, Rabins PV, Seeman MV, Jeste DV. Late-onset schizophrenia and very-late-onset schizophrenia-like psycho- sis: an international consensus. Am J Psychiatry 2000;157:172–8.
  • Almeida OP. Early- vs. late-onset schizophrenia: is it time to define the difference? [Letter]. Am J Geriatr Psychiatry 1998; 6:345–7.
  • Andreasen NC. I don’t believe in late onset schizophrenia. In: Howard R, Rabins PV, Castle DJ, eds. Late-onset schizophre- nia. Philadelphia: Wrightson Biomedical Publishing, 1999: 111–23.
  • Crespo-Facorro B, Piven ML, Schultz SK. Psychosis in late life: how does it fit into current diagnostic criteria? Am J Psy- chiatry 1999;156:624–9.
  • Jeste DV, Palmer BW, Harris MJ. Early- vs. late-onset schizo- phrenia: is it time to define the difference? [Response to Al- meida]. Am J Geriatr Psychiatry 1998;6:346–7.
  • McClure FS, Gladsjo JA, Jeste DV. Late onset psychosis: clini- cal, research, and ethical considerations. Am J Psychiatry 1999;156:935–40.
  • Hafner H, An der Heiden W, Behrens S, Gattaz WF, Ham- brecht M, Loffler W, et al. Causes and consequences of the gen- der difference in age at onset of schizophrenia. Schizophr Bull 1998;24:99–113.
  • Lindamer LA, Lohr JB, Harris MJ, Jeste DV. Gender, estro- gen, and schizophrenia. Psychopharmacol Bull 1997;33:221–8.
  • Lindamer LA, Lohr JB, Harris MJ, McAdams LA, Jeste DV. Gender-related clinical differences in older patients with schizophrenia. J Clin Psychiatry 1999;60:61–7.
  • Seeman MV. The role of estrogen in schizophrenia. J Psychia- try Neurosci 1996;21:123–7.
  • Kraepelin E. Dementia praecox and paraphrenia. Chicago: Chicago Medical Book, 1919.
  • Jeste DV, Symonds LL, Harris MJ, Paulsen JS, Palmer BW, Heaton RK. Nondementia nonpraecox dementia praecox? Late- onset schizophrenia. Am J Geriatr Psychiatry 1997;5:302–17.
  • Jeste DV, Harris MJ, Krull A, Kuck J, McAdams LA, Heaton R. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry 1995;152:722–30.
  • Lohr JB, Alder M, Flynn K, Harris MJ, McAdams LA. Minor physical anomalies in older patients with late-onset schizo- phrenia, early-onset schizophrenia, depression, and Alzhei- mer’s disease. Am J Geriatr Psychiatry 1997;5:318–23.
  • Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV. Quantitative magnetic resonance imaging in late-life schizo- phrenia. Am J Psychiatry 1995;152:447–9.
  • Andreasen NC, Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 1982;39:789–94.
  • Abrams S, Nathanson IA. Intellectual deficit in schizophrenia: stable or progressive. Dis Nerv Syst 1966;27:115–7.
  • Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, et al. Severity of symptoms in chronically institu- tionalized geriatric schizophrenic patients. Am J Psychiatry 1995;152:197–207.
  • Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, et al. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized pa- tients. Biol Psychiatry 1999;45:32–40.
  • Cohen CI, Cohen GD, Blank K, Gaitz C, Katz IR, Leuchter A, et al. Schizophrenia and older adults. An overview: directions for research and policy. Am J Geriatr Psychiatry 2000;8:19–28.
  • Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayer- hoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18:437–48.
  • Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bil- ker W, et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and behavioral measures. Arch Gen Psychiatry 1998; 55:145–52.
  • Belitsky R, McGlashan TH. The manifestations of schizophre- nia in late life: a dearth of data. Schizophr Bull 1993;19:683–5.
  • Cohen CI. Outcome of schizophrenia into later life: an over- view. Gerontologist 1990;30:790–7.
  • Heaton RK, Paulsen JS, McAdams LA, Kuck J, Zisook S, Braff D, et al. Neuropsychological deficits in schizophrenia: rela- tionship to age, chronicity, and dementia. Arch Gen Psychiatry 1994;51:469–76.
  • Heaton RK, Drexler M. Clinical neuropsychological find- ings in schizophrenia and aging. In: Miller NE, Cohen GD, eds. Schizophrenia and aging. New York: Guilford, 1987:145–61.
  • Hyde TM, Nawroz S, Goldberg TE, Bigelow LB, Strong D, Weinberger DR, et al. Is there cognitive decline in schizo- phrenia? A cross-sectional study. Br J Psychiatry 1994;164:494–500.
  • Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001;58:24–32.
  • Eyler Zorrilla LT, Heaton RK, McAdams LA, Zisook S, Harris MJ, Jeste DV. Cross-sectional study of older outpatients with schizophrenia and healthy comparison subjects: no differences in age-related cognitive decline. Am J Psychiatry 2000;157:1324–6.
  • Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606–18.
  • Harding CM, Brooks GW, Ashikaga T, Strauss JS, Landerl PD. Aging and social functioning in once-chronic schizophrenic pa- tients 22-62 years after first admission: the Vermont story. In: Miller NE, Cohen GD, eds. Schizophrenia and aging. New York: Guilford, 1987:74–82.
  • Huber G. The heterogeneous course of schizophrenia. Schizophr Res 1997;28:177–85.
  • Nasar S. A beautiful mind. New York: Simon & Schuster, 1998.
  • Volz J. Consumers are unhappy with clinicians’ efforts in treat- ing mental illness. American Psychological Association Moni- tor Online, October 1999. [Abstract available on the World Wide Web: http://www.apa.org/monitor/oct99/cf1.html (ac- cessed January 23, 2001).]
  • Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The nat- ural course of schizophrenia: a review of first-admission stud- ies. Schizophr Bull 1992;18:185–207.
  • Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychia- try 1988;145:578–83.
  • Crow TJ. Molecular pathology of schizophrenia: more than one disease process? BMJ 1980;280:66–8.
  • Wyatt RJ. Neuroleptics and the natural course of schizophre- nia. Schizophr Bull 1991;17:325–51.
  • Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, et al. Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990;147:1138–48.
  • Schooler N, Keith SJ, Severe JB, Matthews SM. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies. Psychiatr Q 1995;66:279–92.
  • National Institute of Mental Health. Abnormal Involuntary Movement Scale. In: Guy W, ed. ECDEU assessment manual for psychopharmacology—revised. Rockville, Maryland: US Dept of Health, Education, and Welfare, 1976. Publication (ADM)76-338:534–7.
  • Buchanan RW, Gold JM. Negative symptoms: diagnosis, treat- ment and prognosis. Int Clin Psychopharmacol 1996;11:3–11.
  • Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716–9.
  • Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J. Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70–6.
  • Marder SR, Wirshing WC, Mintz J, McKenzie J, Johnston K, Eckman TA, et al. Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. Am J Psychiatry 1996;153:1585–92.
  • Penn DL, Mueser KT. Research update on the psychosocial treatment of schizophrenia. Am J Psychiatry 1996;153:607–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.